Inuvo, Inc. Reports Third Quarter Sequential Revenue

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Inuvo, Inc. Reports Third Quarter Sequential Revenue Increases 19% and Net Income of $0.02 per Share

CONWAY, AR--(Marketwired - Oct 30, 2014) - Inuvo, Inc. ( NYSE MKT : INUV ), an Internet marketing and technology company that delivers purchase-ready customers to advertisers through a broad network of desktop and mobile websites and apps, today announced net income of $403,000 or $0.02 per diluted share for the third quarter of 2014. Revenue for the quarter was $13 million, compared to $10.9 million in the second quarter of 2014 and $14.5 million for the third quarter of 2013. Adjusted EBITDA was $1.2 million in the third quarter of 2014 compared to $1.2 million in the second quarter of 2014 and $1.5 million in the third quarter of 2013.

"Sequential growth and net income have so far exceeded our expectations in 2014. We have been able to deliver solid results across the board through the first nine months with both business segments reporting double digit compounded sequential quarterly growth while also positively contributing to our mobile expansion objectives, where revenue in the quarter reached 49% of the total," stated Richard Howe, Chairman and Chief Executive Officer of Inuvo. "We believe we are on the right track with solid quarterly financial performance, a stronger balance sheet and the successful transition out of a product line that represented half of 2012's revenue."

Third Quarter 2014 Highlights

  • Net income was $403,000 or $0.02 per diluted share.
  • ALOT sites and applications revenue was $5.6 million, a 187% improvement over 2013.
  • Adjusted EBITDA, a non-GAAP measure, was $1.2 million.
  • The Partner Segment grew 27% and the Owned & Operated Segment grew 10% sequentially.
  • Revenue and quality per lead delivered to clients had double digit percentage improvements.
  • Appbar revenue was less than $350,000 dollars.

First Nine Months 2014 Highlights

  • Net income was $1.5 million or $0.06 per diluted share, a 100% improvement over 2013.
  • ALOT sites revenue was $14.1 million, a 134% improvement over 2013.
  • Adjusted EBITDA was $3.7 million unchanged from the first nine months of 2013.
  • Revenue has grown from $10.1 million, to $10.9 million, to $13 million in the first, second and third quarters, respectively.

The Inuvo business is managed along two segments, the Partner Network and the Owned and Operated Network. The Partner Network facilitates transactions between advertisers and our partners' websites and applications. The Owned and Operated Network designs, builds and markets mobile-ready consumer websites and applications under the ALOT brand. The segments share the utilization of the company's core ad delivery technology platform. 

Three-month financial results for the period ended September 30, 2014

Net revenue for the three months ended September 30, 2014, was $13 million as compared to $14.5 million for the three months ended September 30, 2013. While there were both increases in the Owned and Operated Network and decreases in the Partner Network over this period, the principal reason for the overall decline revolves around the stated strategy to transition out of the Appbar product. Appbar revenue for the three months period decreased from $1.75 million in 2013 to $0.35 million in 2014 and for the nine month period decreased from $9.3 million in 2013 to $1.87 million in 2014. We expect the Appbar revenue to be near zero by the end of 2014. In addition, we incurred lower revenue but higher margin in the Partner Network in the quarter ended September 30, 2014 compared to the same quarter last year due to a focus on delivering higher quality clicks and the continued enforcement of publisher contract terms and conditions associated with that strategy. Revenue in our Owned and Operated Network was $5.9 million in the third quarter of 2014 compared to $3.7 million in the same quarter last year and reflects the transition from toolbar to content rich websites and applications within the segment. Though Marketing expense was higher in the third quarter 2014 compared to the same quarter last year due to the launching of owned & operated websites and applications, both Compensation expense and Selling, general and administrative expense ran below last year.

For the quarter ended September 30, 2014, Adjusted EBITDA, a non-GAAP measure was $1.2 million largely unchanged from the third quarter of 2013. The Company reported net income of $403,000, or $0.02 per diluted share, for the three months ended September 30, 2014.

Balance Sheet as of September 30, 2014 Cash and cash equivalents totaled $3.5 million at September 30, 2014. Current assets and total assets were $9 million and $25.8 million, respectively and current liabilities and total liabilities were $11.1 million and $18.4 million, respectively, as of September 30, 2014. Bank debt was reduced to $4.5 million from $6.1 million at December 31, 2013. Stockholders' equity was approximately $7.4 million at September 30, 2014.

Conference Call Information Date: Thursday, October 30, 2014 Time: 4:15 p.m. EDT Domestic Dial-in number: 1-877-681-3374 International Dial-in number: 1-719-325-4749 Live webcast: http://public.viavid.com/index.php?id=111574

In addition, the call will be webcast on the Investor Relations section of the Company's website at http://investor.inuvo.com/events_and_presentations where it will also be archived for 45 days. A telephone replay will be available through Thursday, November 13, 2014. To access the replay, please dial 1-877-870-5176 (domestic) or 1-858-384-5517 (international). At the system prompt, enter the code 3233229 followed by the # sign. You will then be prompted for your name, company and phone number. Playback will then automatically begin.

About Inuvo, Inc. Inuvo®, Inc. ( NYSE MKT : INUV ) is an Internet marketing and technology company that delivers purchase-ready customers to advertisers through a broad network of desktop and mobile websites and apps. To learn more about Inuvo, please visit www.inuvo.com .

Forward-looking Statements This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words or expressions such as "anticipate," "plan," "will," "intend," "believe" or "expect'" or variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to expectations with respect to our lack of profitable operating history, changes in our business, potential need for additional capital, fluctuations in demand; changes to economic growth in the U.S. economy; and government policies and regulations, including, but not limited to those affecting the Internet, all as set forth in our Annual Report on Form 10-K for the year ended December 31, 2013 and our most recent Form 10-Q. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of Inuvo and are difficult to predict. Inuvo undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

 
INUVO, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
         
    (Unaudited)    
    September 30,   December 31,
    2014   2013
Assets            
Current assets            
  Cash   $ 3,459,946   $ 3,137,153
  Accounts receivable, net     5,105,414     3,609,825
  Unbilled revenue     19,013     24,472
  Prepaid expenses and other current assets     426,189     510,968
Total current assets     9,010,562     7,282,418
             
Property and equipment, net     1,031,956     1,188,566
Goodwill     5,760,808     5,760,808
Intangible assets, net     9,728,823     10,324,326
Other assets     229,247     379,513
Total assets   $ 25,761,396   $ 24,935,631
             
Liabilities and Stockholders' Equity            
Current liabilities            
  Accounts payable   $ 6,642,228   $ 6,235,533
  Accrued expenses and other current liabilities     2,772,990     2,386,226
  Term and credit notes payable, current portion     1,659,942     2,548,333
Total current liabilities     11,075,160     11,170,092
             
Deferred tax liability     3,713,205     3,788,903
Term and credit notes payable, long term     2,833,333     3,595,300
Other long-term liabilities     775,399     1,039,470
Total liabilities     18,397,097     19,593,765
             
Total stockholders' equity     7,364,299     5,341,866
Total liabilities and stockholders' equity   $ 25,761,396   $ 24,935,631
             
                     
                     
INUVO, INC.  
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME  
   
    (Unaudited)              
    Three Months Ended     Nine Months Ended  
    September 30, 2014     September 30, 2013     September 30, 2014     September 30, 2013  
Net revenue   $ 13,026,011     $ 14,509,050     $ 34,089,761     $ 43,559,257  
Cost of revenue     5,910,719       8,183,064       14,253,649       22,628,243  
Gross profit     7,115,292       6,325,986       19,836,112       20,931,014  
Operating expenses                                
  Marketing costs     4,277,446       2,939,584       11,555,731       10,625,638  
  Compensation     1,192,227       1,412,842       3,431,237       4,727,936  
  Selling, general and administrative     1,180,940       1,360,610       3,245,904       5,270,986  
Total operating expenses     6,650,613       5,713,036       18,232,872       20,624,560  
Operating income     464,679       612,950       1,603,240       306,454  
Other expense, net     (84,870 )     (98,451 )     (285,973 )     (271,448 )
Net income from continuing operations before taxes     379,809       514,499       1,317,267       35,006  
Income tax benefit     -       75,699       75,698       237,946  
Net income from continuing operations     379,809       590,198       1,392,965       272,952  
Net income from discontinued operations     23,065       49,601       66,959       457,709  
Net income     402,874       639,799       1,459,924       730,661  
Other comprehensive income                                
  Foreign currency revaluation     -       (294 )     -       (418 )
Total comprehensive income   $ 402,874     $ 639,505     $ 1,459,924     $ 730,243  
Earnings per share, basic and diluted                                
  From continuing operations   $ 0.02     $ 0.03     $ 0.06     $ 0.01  
  From discontinued operations     -       -       -       0.02  
Net income   $ 0.02     $ 0.03     $ 0.06     $ 0.03  
Weighted average shares outstanding                                
  Basic     23,445,771       23,291,468       23,485,052       23,278,003  
  Diluted     24,143,194       23,447,301       23,855,148       23,329,551  
                                 
By Segment (Unaudited):                                
Net revenue                                
  Partner Network   $ 7,089,584     $ 10,807,377     $ 18,110,706     $ 28,232,281  
  Owned and Operated Network     5,936,427       3,701,673       15,979,055       15,326,976  
    Total   $ 13,026,011     $ 14,509,050     $ 34,089,761     $ 43,559,257  
Gross profit                                
  Partner Network   $ 1,207,382     $ 2,793,999     $ 4,024,984     $ 6,456,050  
  Owned and Operated Network     5,907,910       3,531,987       15,811,128       14,474,964  
    Total   $ 7,115,292     $ 6,325,986     $ 19,836,112     $ 20,931,014  
                                     
                                     
 
INUVO, INC.
RECONCILIATION OF NET INCOME FROM CONTINUING OPERATIONS BEFORE TAXES TO ADJUSTED EBITDA
(Unaudited)
                   
    Three Months Ended     Nine Months Ended
    September 30, 2014   September 30, 2013     September 30, 2014   September 30, 2013
Net income from continuing operations before taxes   $ 379,809   $ 514,499     $ 1,317,267   $ 35,006
Interest expense, net     84,870     98,451       285,973     271,448
Depreciation     225,924     409,685       725,231     1,619,719
Amortization     198,501     198,501       595,503     944,168
Stock-based compensation     279,970     239,353       658,800     539,766
Severances and other non-recurring, non-cash items     8,074     (623 )     126,017     264,190
                           
Adjusted EBITDA   $ 1,177,148   $ 1,459,866     $ 3,708,791   $ 3,674,297
                           
                           

Reconciliation of Net Income from Continuing Operations before Taxes to Adjusted EBITDA

In addition to disclosing financial results in accordance with United States generally accepted accounting principles ("GAAP"), our earnings release contains the non-GAAP financial measure "Adjusted EBITDA."

Adjusted EBITDA is not a measure of performance defined in accordance with GAAP. However, management believes that Adjusted EBITDA is useful to investors in evaluating the Company's performance because Adjusted EBITDA is a commonly used financial analysis tool for measuring and comparing companies in the Company's industry in areas of operating performance.

Management believes that the disclosure of Adjusted EBITDA offers an additional view of the Company's operations that, when coupled with the GAAP results and the reconciliation to GAAP net income, provides a more complete understanding of the Company's results of operations and the factors and trends affecting the Company's business.

We present Adjusted EBITDA as a supplemental measure of our performance. We defined Adjusted EBITDA as net income from continuing operations before taxes plus (i) interest expense, net, (ii) depreciation, (iii) amortization, (iv) stock-based compensation, and (v) accrued severance and other non-recurring, noncash expense. These further adjustments are itemized above. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same or similar to some of the adjustments in the presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

Inuvo, Inc. Wally Ruiz Chief Financial Officer 501-205-8397 Email Contact or Investor Relations Capital Markets Group Alan Sheinwald 914-669-0222 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading